Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 15,000 shares at $305.25 ($4.5M) on 2014-03-24, disclosed to the SEC on 2014-03-25.
Scheduled sale ($4.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.09 | 10,200 | $3.1M | 67.4% |
| 2 | $301.12 | 700 | $211K | 4.6% |
| 3 | $302.90 | 100 | $30K | 0.7% |
| 4 | $303.64 | 300 | $91K | 2.0% |
| 5 | $304.42 | 300 | $91K | 2.0% |
| 6 | $305.25 | 200 |
| $61K |
| 1.3% |
| 7 | $307.65 | 300 | $92K | 2.0% |
| 8 | $308.25 | 400 | $123K | 2.7% |
| 9 | $310.80 | 600 | $186K | 4.1% |
| 10 | $311.46 | 1,200 | $374K | 8.2% |
| 11 | $312.29 | 600 | $187K | 4.1% |
| 12 | $313.40 | 100 | $31K | 0.7% |
| Total | $302.67 avg | 15,000 | $4.5M | 100% |
| Filing → |
| REGN | SELL | 2015-09-18 | $2.8M | — | Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2013-10-02 | $4.7M | — | Filing → |